CEREBRUM

Serial Number 97979637
807

Registration Progress

Application Filed
Feb 7, 2023
Under Examination
Jun 4, 2024
Approved for Publication
Oct 17, 2023
Published for Opposition
Oct 17, 2023
Registered

Basic Information

Serial Number
97979637
Filing Date
February 7, 2023
Published for Opposition
October 17, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
807
Status Date
Mar 19, 2025
Application
Pending
Classes
042 044

Rights Holder

Praxis Precision Medicines, Inc.

03
Address
99 High Street, 30th Floor
Boston, MA 02110

Ownership History

Praxis Precision Medicines, Inc.

Original Applicant
03
Boston, MA

Praxis Precision Medicines, Inc.

Owner at Publication
03
Boston, MA

Legal Representation

Attorney
Michael H. Jacobs

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

32 events
Date Code Type Description
Jun 18, 2025 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 18, 2025 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Mar 21, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 21, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 21, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 19, 2025 GNRT O NON-FINAL ACTION E-MAILED
Mar 19, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 19, 2025 CNRT W SU - NON-FINAL ACTION - WRITTEN
Mar 18, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Feb 19, 2025 DPCC D DIVISIONAL PROCESSING COMPLETE
Feb 11, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 27, 2024 EISU I TEAS STATEMENT OF USE RECEIVED
Nov 27, 2024 ERTD I TEAS REQUEST TO DIVIDE RECEIVED
Nov 27, 2024 DRRR I DIVISIONAL REQUEST RECEIVED
Nov 27, 2024 IUAF S USE AMENDMENT FILED
Jun 4, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 25, 2024 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Apr 5, 2024 CHPB I POST PUBLICATION AMENDMENT - ENTERED
Apr 2, 2024 APET A ASSIGNED TO PETITION STAFF
Feb 28, 2024 EPPA I TEAS POST PUBLICATION AMENDMENT RECEIVED
Nov 13, 2023 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED
Oct 17, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 17, 2023 PUBO A PUBLISHED FOR OPPOSITION
Sep 27, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 8, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 7, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED
Sep 7, 2023 GNEA F EXAMINERS AMENDMENT E-MAILED
Sep 7, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 7, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN
Sep 5, 2023 DOCK D ASSIGNED TO EXAMINER
Feb 27, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 10, 2023 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 042
Providing medical and scientific research information in the field of pharmaceutical research for the treatment of neurological disorders and central nervous system disorders
First Use Anywhere: Feb 6, 2023
First Use in Commerce: Feb 6, 2023
Class 044
Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals for the treatment of neurological disorders and central nervous system disorders; providing information in the field of treatment of neurological disorders and central nervous system disorders; consulting services in the field of pharmaceuticals for the treatment of neurological disorders and central nervous system disorders
First Use Anywhere: Feb 6, 2023
First Use in Commerce: Feb 6, 2023

Classification

International Classes
042 044